Organogenesis Holdings Inc. (ORGO) Financials
ORGO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 460.0 million | 181.4 million |
2023-09-30 | 462.6 million | 185.8 million |
2023-06-30 | 450.3 million | 179.0 million |
2023-03-31 | 446.1 million | 182.4 million |
ORGO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 7.3 million | 2.4 million |
2023-09-30 | 10.8 million | 2.4 million |
2023-06-30 | 1.1 million | 2.3 million |
2023-03-31 | -12.6 million | 1.9 million |
ORGO Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | -568000 |
2023-09-30 | 3.2 million |
2023-06-30 | 5.3 million |
2023-03-31 | -3.0 million |
ORGO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 104.3 million | - | 53.1 million |
2023-09-30 | 98.2 million | - | 57.4 million |
2023-06-30 | 88.9 million | - | 55.8 million |
2023-03-31 | 88.7 million | - | 52.5 million |
ORGO Shares Outstanding
ORGO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 3.3 million | 11.8 million | 61.4 million | - |
2023-09-30 | 6.0 million | 10.5 million | 64.2 million | - |
2023-06-30 | 7.5 million | 10.9 million | 70.3 million | - |
2023-03-31 | 7.6 million | 11.2 million | 73.8 million | - |
ORGO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 99.7 million | 31.9 million |
2023-09-30 | 108.5 million | 25.8 million |
2023-06-30 | 117.3 million | 26.3 million |
2023-03-31 | 107.6 million | 26.6 million |
ORGO
Price: $2.35
52 week price:
Earnings Per Share: 0.04 USD
P/E Ratio: 33.30
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 317113
Market Capitalization: 380.1 million